Genmab A/S
GMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $97,160 | $141,717 | $192,457 | $169,123 |
| - Cash | $9,858 | $14,867 | $9,893 | $8,957 |
| + Debt | $1,029 | $770 | $597 | $425 |
| Enterprise Value | $88,331 | $127,620 | $183,161 | $160,591 |
| Revenue | $21,526 | $16,474 | $14,505 | $8,417 |
| % Growth | 30.7% | 13.6% | 72.3% | – |
| Gross Profit | $20,541 | $16,248 | $14,505 | $8,417 |
| % Margin | 95.4% | 98.6% | 100% | 100% |
| EBITDA | $9,697 | $5,947 | $7,346 | $4,181 |
| % Margin | 45% | 36.1% | 50.6% | 49.7% |
| Net Income | $7,844 | $4,352 | $5,452 | $2,957 |
| % Margin | 36.4% | 26.4% | 37.6% | 35.1% |
| EPS Diluted | 12.14 | 6.6 | 8.26 | 4.48 |
| % Growth | 83.9% | -20.1% | 84.4% | – |
| Operating Cash Flow | $7,771 | $7,380 | $3,912 | $2,228 |
| Capital Expenditures | -$187 | -$376 | -$317 | -$252 |
| Free Cash Flow | $7,584 | $7,004 | $3,595 | $1,976 |